Syndax Pharmaceuticals won the first FDA approval last week in a new class of medicines called menin inhibitors. The treatment, Rejuforj, will be available as soon as this month for patients with an ...

Syndax Pharmaceuticals (SNDX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Kelly ...

The US Food and Drug Administration (FDA) has approved Syndax Pharmaceuticals' Revuforj (revumenib) for treating relapsed or ...

Edward White, an analyst from H.C. Wainwright, reiterated the Buy rating on Syndax Pharmaceuticals (SNDX – Research Report). The associated ...

The US Food and Drug Administration has approved revumenib (Revuforj — Syndax Pharmaceuticals) for relapsed or refractory ...

Explore this weekend's OTT releases across Malayalam, Tamil, and Telugu. Thrillers, action, and dramas, including Kishkindha ...

I just threw in that little trick you told me, laughing like a mad man. You promised 1000 euros and got votes. I promised ...

Bitcoin appeared poised to make another run at $70,000, but a WSJ story of a criminal probe into the stablecoin issuer sent prices tumbling Friday afternoon.

Karnataka is witnessing a direct contest between the ruling Bharatiya Janata Party (BJP) and Congress. However, the Janata Dal - Secular (JD-S) is eyeing the kingmakers status. Among the top ...